Analyst upgrades, downgrades and initiations: ABT, BA, CLWR, LLY, LTD, NFLX ...

More

Analyst upgrades:

  • Stephens upgraded Quidel (QDEL) to equal weight from underweight on valuation following the recent pullback in shares. The firm keeps a $16 price target on the stock.
  • UBS upgraded Clearwire (CLWR) to neutral from sell, citing the company's funding, which increases opportunities. The firm raised its price target to $6 from $3.
  • Oppenheimer upgraded Mattson Technology (MTSN) to outperform from perform on expectations the company will benefit from a cyclical recovery in memory capex spending in 2010. The firm raised its target on shares to $4 from $3.
  • Eli Lilly (LLY) was upgraded to sell from conviction sell at Goldman.
  • Kinross Gold (KGC) was upgraded to overweight from neutral at JPMorgan.
  • Limited Brands (LTD) was upgraded to hold from sell at Soleil.

Analyst downgrades:

  • MerrMerriman downgraded Netflix (NFLX) to neutral from buy on valuation and concern that subscriber additions from launches on PS3 and Xbox 360 could pressure near-term earnings.
  • RBC Capital downgraded Church & Dwight (CHD) to outperform from a top pick and said it would look to be more aggressive on pull backs. The firm has a $66 target on shares.
  • JMP Securities downgraded NuVasive (NUVA) to market perform from outperform, citing reimbursement concerns.
  • Abbott Lab (ABT) was cut to buy from conviction buy at Goldman.

Analyst initiations:

  • Kaufman Bros. believes Standard Microsystems (SMSC) is well-positioned as a mixed-signal analog vendor. Shares were initiated with a buy rating and $23 target.
  • Benchmark Co. believes Equinix (EQIX) will benefit from increasing usage of web-based communications services. The firm set a buy rating and $120 price target on shares.
  • Morgan Stanley initiated Santander Brasil (BSBR) with an overweight rating and $17 target, citing relative valuation.
  • Boeing (BA) was started with an underweight rating and $45 target at HSBC.
  • Alpha Natural (ANR) was assumed at BofA/Merrill with a buy rating and $50 target.
  • Perrigo (PRGO) was initiated with an outperform rating and $50 target at RBC Capital.

Add your comments

Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.

When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.

To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br /> tags.

Symbol Lookup
IndexesChangePrice
DJIA+150.2510,058.64
NASDAQ+24.822,150.87
S&P 500+13.781,070.52

Last updated: February 10, 2010: 12:21 AM

Hot Stocks

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines